In summary, we uncovered that arctigenin exerted anti-tumor effect through decreasing tumor-derived GM-CSF and TSLP, and targeting the proliferation, invasion and stemness of breast cancer cells. This evidence concerns the gene CSF2 and breast carcinoma.